These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29496458)

  • 1. Aerosol characterisation of nebulised liposomes co-loaded with erlotinib and genistein using an abbreviated cascade impactor method.
    Nimmano N; Somavarapu S; Taylor KMG
    Int J Pharm; 2018 May; 542(1-2):8-17. PubMed ID: 29496458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooling the NGI - an approach to size a nebulised aerosol more accurately.
    Dennis J; Berg E; Sandell D; Ali A; Lamb P; Tservistas M; Karlsson M; Mitchell J
    Pharmeur Sci Notes; 2008 Feb; 2008(1):27-30. PubMed ID: 18430404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers.
    Najlah M; Parveen I; Alhnan MA; Ahmed W; Faheem A; Phoenix DA; Taylor KM; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):234-41. PubMed ID: 24275450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
    Rao N; Kadrichu N; Ament B
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the need to coat particle collection cups of the NGI to mitigate droplet bounce when evaluating nebuliser-produced droplets.
    Berg E; Lamb P; Ali A; Dennis J; Tservistas M; Mitchell J
    Pharmeur Sci Notes; 2008 Feb; 2008(1):21-5. PubMed ID: 18430403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
    Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
    Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
    Waldrep JC; Berlinski A; Dhand R
    J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI).
    Mohan M; Lee S; Guo C; Peri SP; Doub WH
    AAPS PharmSciTech; 2017 Jul; 18(5):1585-1594. PubMed ID: 27624069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology.
    Elhissi A; Hidayat K; Phoenix DA; Mwesigwa E; Crean S; Ahmed W; Faheem A; Taylor KM
    Int J Pharm; 2013 Feb; 444(1-2):193-9. PubMed ID: 23299083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nebulised aerosol size on lung deposition in patients with mild asthma.
    Clay MM; Clarke SW
    Thorax; 1987 Mar; 42(3):190-4. PubMed ID: 3303427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannitol delivery by vibrating mesh nebulisation for enhancing mucociliary clearance.
    Chan JG; Kwok PC; Young PM; Chan HK; Traini D
    J Pharm Sci; 2011 Jul; 100(7):2693-702. PubMed ID: 21283985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multi-laboratory in Vitro Study to Compare Data from Abbreviated and Pharmacopeial Impactor Measurements for Orally Inhaled Products: a Report of the European Aerosol Group (EPAG).
    Nichols SC; Mitchell JP; Sandell D; Andersson PU; Fischer M; Howald M; Pengilley R; Krüger P
    AAPS PharmSciTech; 2016 Dec; 17(6):1383-1392. PubMed ID: 26762338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to characterise pharmaceutical aerosols: measurement of aerosol from a single dose aqueous inhaler with an optical particle counter.
    Kuhli M; Weiss M; Steckel H
    Eur J Pharm Sci; 2010 Jan; 39(1-3):45-52. PubMed ID: 19874891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of some of the factors influencing the jet nebulisation of liposomes.
    Bridges PA; Taylor KM
    Int J Pharm; 2000 Aug; 204(1-2):69-79. PubMed ID: 11011988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
    Elhissi AM; Giebultowicz J; Stec AA; Wroczynski P; Ahmed W; Alhnan MA; Phoenix D; Taylor KM
    Int J Pharm; 2012 Oct; 436(1-2):519-26. PubMed ID: 22796173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.
    Dennis JH; Stenton SC; Beach JR; Avery AJ; Walters EH; Hendrick DJ
    Thorax; 1990 Oct; 45(10):728-32. PubMed ID: 2247862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.